| __timestamp | Soleno Therapeutics, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 2242216 | 55430000 |
| Thursday, January 1, 2015 | 4536244 | 65510000 |
| Friday, January 1, 2016 | 5184803 | 71160000 |
| Sunday, January 1, 2017 | 3068742 | 70644000 |
| Monday, January 1, 2018 | 7178000 | 70418000 |
| Tuesday, January 1, 2019 | 16267000 | 63238000 |
| Wednesday, January 1, 2020 | 23191000 | 59777000 |
| Friday, January 1, 2021 | 21453000 | 60152000 |
| Saturday, January 1, 2022 | 15265000 | 54540000 |
| Sunday, January 1, 2023 | 25189000 | 52243000 |
| Monday, January 1, 2024 | 64536000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, innovation is key. Soleno Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. have been investing in research and development (R&D) to stay ahead. From 2014 to 2023, Taro consistently outspent Soleno, with R&D expenses peaking at approximately $71 million in 2016. In contrast, Soleno's highest investment was around $25 million in 2023, marking a significant increase from its 2014 expenditure of just over $2 million. This trend highlights Taro's commitment to innovation, spending nearly three times more on average than Soleno. However, Soleno's recent surge in R&D spending suggests a strategic pivot towards innovation. Missing data for 2024 indicates potential changes in reporting or strategy. As the pharmaceutical landscape evolves, these investments could shape the future of healthcare innovation.
Research and Development Investment: Johnson & Johnson vs Soleno Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Soleno Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Gilead Sciences, Inc. and Taro Pharmaceutical Industries Ltd.
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Soleno Therapeutics, Inc.
Regeneron Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: argenx SE vs Soleno Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Madrigal Pharmaceuticals, Inc. and Soleno Therapeutics, Inc.
Research and Development Investment: TG Therapeutics, Inc. vs Soleno Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for PTC Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd.
Who Prioritizes Innovation? R&D Spending Compared for Vericel Corporation and Soleno Therapeutics, Inc.
HUTCHMED (China) Limited vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Taro Pharmaceutical Industries Ltd. or Viridian Therapeutics, Inc.: Who Invests More in Innovation?